BP Lipid 312

BP Lipid 312

BP Lipid 312 is a proprietary ionizable lipid developed by BroadPharm, designed for comparison with lipid LP01 and other related lipids. It features a key structural modification—the substitution of a polyunsaturated tail with a monounsaturated equivalent—which may influence lipid nanoparticle performance. BP Lipid 312 has been utilized in the formulation of lipid nanoparticles (LNPs) for the delivery of CRISPR-Cas9 RNA, as demonstrated in product citations (see below). For inquiries regarding GMP-grade material, please contact us directly.

Molecular structure of the compound BP-40215
    • Unit
    • Price
    • Qty
    • 25 MG
    • $340.00
    • 50 MG
    • $540.00
    • 100 MG
    • $860.00
    • 250 MG
    • $1500.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Chen, K., Han, H., Zhao, S., Xu, B., Yin, B., Lawanprasert, A., ... & Doudna, J. A. (2024). Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein. Nature Biotechnology, 1-13.
    https://www.nature.com/articles/s41587-024-02437-3